Literature DB >> 2986673

Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins.

D R Marshak, T J Lukas, D M Watterson.   

Abstract

The quantitative binding of a phenothiazine drug to calmodulin, calmodulin fragments, and structurally related calcium binding proteins was measured under conditions of thermodynamic equilibrium by using a gel filtration method. Plant and animal calmodulins, troponin C, S100 alpha, and S100 beta bind chlorpromazine in a calcium-dependent manner with different stoichiometries and affinities for the drug. The interaction between calmodulin and chlorpromazine appears to be a complex, calcium-dependent phenomenon. Bovine brain calmodulin bound approximately 5 mol of drug per mol of protein with apparent half-maximal binding at 17 microM drug. Large fragments of calmodulin had limited ability to bind chlorpromazine. The largest fragment, containing residues 1-90, retained only 5% of the drug binding activity of the intact protein. A reinvestigation of the chlorpromazine inhibition of calmodulin stimulation of cyclic nucleotide phosphodiesterase further indicated a complex, multiple equilibrium among the reaction components and demonstrated that the order of addition of components to the reaction altered the drug concentration required for half-maximal inhibition of the activity over a 10-fold range. These results confirm previous observations using immobilized phenothiazines [Marshak, D.R., Watterson, D.M., & Van Eldik, L.J. (1981) Proc. Natl. Acad. Sci. U.S.A. 78, 6793-6797] that indicated a subclass of calcium-modulated proteins bound phenothiazines in a calcium-dependent manner, demonstrate that the interaction between phenothiazines and calmodulin is more complex than previously assumed, and suggest that extended regions of the calmodulin molecule capable of forming the appropriate conformation are required for specific, high-affinity, calcium-dependent drug binding activity.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2986673     DOI: 10.1021/bi00322a020

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Inhibition of cyclosporin A/FK506 resistant, lymphokine-induced T-cell activation by phenothiazine derivatives.

Authors:  M Schleuning; V Brumme; W Wilmanns
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

2.  Ebola virus uses clathrin-mediated endocytosis as an entry pathway.

Authors:  Suchita Bhattacharyya; Kelly L Warfield; Gordon Ruthel; Sina Bavari; M Javad Aman; Thomas J Hope
Journal:  Virology       Date:  2010-03-03       Impact factor: 3.616

3.  Up-regulation expressions of lysyl oxidase family in Anterior Cruciate Ligament and Medial Collateral Ligament fibroblasts induced by Transforming Growth Factor-Beta 1.

Authors:  Jing Xie; Jiahuan Jiang; Yanjun Zhang; Chunming Xu; Lin Yin; Chunli Wang; Peter C Y Chen; K L Paul Sung
Journal:  Int Orthop       Date:  2011-06-15       Impact factor: 3.075

4.  Spectral studies of the Ca2+-dependent interaction of trifluoperazine with S100b.

Authors:  P L Pingerelli; H Mizukami; M J Mooney; A L Schlaepfer
Journal:  J Protein Chem       Date:  1989-04

5.  Ca2+-bound calmodulin forms a compact globular structure on binding four trifluoperazine molecules in solution.

Authors:  N Matsushima; N Hayashi; Y Jinbo; Y Izumi
Journal:  Biochem J       Date:  2000-04-01       Impact factor: 3.857

6.  Markov state modelling reveals heterogeneous drug-inhibition mechanism of Calmodulin.

Authors:  Annie M Westerlund; Akshay Sridhar; Leo Dahl; Alma Andersson; Anna-Yaroslava Bodnar; Lucie Delemotte
Journal:  PLoS Comput Biol       Date:  2022-10-07       Impact factor: 4.779

7.  Cell entry of arginine-rich peptides is independent of endocytosis.

Authors:  Gohar Ter-Avetisyan; Gisela Tünnemann; Danny Nowak; Matthias Nitschke; Andreas Herrmann; Marek Drab; M Cristina Cardoso
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

8.  Muscle regeneration and mitochondrial calmitine increase in the dystrophic dy/dy mouse after intramuscular chlorpromazine injection.

Authors:  B Lucas-Heron; J P Louboutin; B Ollivier; N Schmitt
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

9.  Systematic discovery of multicomponent therapeutics.

Authors:  Alexis A Borisy; Peter J Elliott; Nicole W Hurst; Margaret S Lee; Joseph Lehar; E Roydon Price; George Serbedzija; Grant R Zimmermann; Michael A Foley; Brent R Stockwell; Curtis T Keith
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-10       Impact factor: 11.205

10.  Intracellular fate of Ureaplasma parvum entrapped by host cellular autophagy.

Authors:  Fumiko Nishiumi; Michinaga Ogawa; Yukiko Nakura; Yusuke Hamada; Masahiro Nakayama; Jiro Mitobe; Atsushi Hiraide; Norio Sakai; Makoto Takeuchi; Tamotsu Yoshimori; Itaru Yanagihara
Journal:  Microbiologyopen       Date:  2017-01-15       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.